Enhanced tumor outgrowth after peptide vaccination: Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors

Journal of Immunology

Volumn 156, Issue 10, 1996, Pages 3911-3918

  Toes, René E M ^a   Blom, Ria J J ^a   Offringa, Rienk ^a   Kast, W Martin ^a,b   Melief, Cornelis J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PEPTIDE AD5E1B; SYNTHETIC PEPTIDE; TUMOR CELL VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR REGRESSION; VACCINATION;

ADENOVIRUS E1A PROTEINS; AMINO ACID SEQUENCE; ANIMALS; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, NUDE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS; VIRAL VACCINES;

EID: 0029935569     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Buchmeier, M J., R. M. Welsh, F. J Dutko, and M. B. A. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol 30:275.
2. Kast, W M , A. M Bronkhorst, L. P de Waal, and C. J. M. Melief. 1986. Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. J. Exp. Med. 164:723
3. Doherty, P. C., W. Allen, M Eichelberger, and S. R. Carding. 1992. Roles of ab and gd T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123.
4. Melief, C. J. M. 1992. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res 58 143
5. Feltkamp, M. C. W., H. L. Smits, M. P. M. Vierboom, R. P Minnaar, B. M. de Jongh, J W. Drijfhout, J. ter Schegget, C J. M. Melief, and W. M. Kast 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells Eur J. Immunol 23 2242
6. + T-cell responses and prolongs survival of thymoma-bearing mice Cancer Res. 54:4155.
7. Townsend, A R. M , J. Rothbard, F. M. Gotch, G Bahadur, D. Wraith, and A. J McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides Cell 44:959
8. Feltkamp, M. C. W., G R Vreugdenhil, M P M. Vierboom, E Ras, S. H van der Burg, J. ter Schegget, C J. M. Meltef, and W M. Kast 1995. CTL raised against a subdominant peptide eradicate human papillomavirus type 16-induced tumors. Eur. J. Immunol. 25.2638.
9. Kast, W. M., L. Roux, J. Curren, H. J J. Blom, A. C Voordouw, R H. Meloen, D. Kolakofsky, and C. J M Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci USA 88:2283.
10. Schulz, M., R. M. Zinkernagel, and H. Hengartner. 1991 Peptide-induced protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 88 991
11. Schild, H , M. Norda, K. Deres, K. Falk, O. Rötzschke, K-H Wiesmuller, G Jung, and H.-G. Rammensee. 1991. Fine specificity of cytotoxic T lymphocytes primed either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide. J. Exp. Med. 174:1665
12. Vitiello, A., G. Ishioka, H M. Grey, R. Rose, P. Farness, R Lafond, L Yuan, F. V Chisari, J. Furze, R. Bartholomeuz, and R. W Chesnut. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chrome HBV infection J Clin. Invest. 95:341.
13. Ressing, M. E., A Sette, R. M. P. Brandt, J. Ruppert, P A Wentworth, M. Hartman, C. Oseroff, H. M Grey, C. J M. Melief, and W. M Kast. 1995. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J. Immunol 154:5934.
14. Mandelboim, O., E. Vafai, M Fridkin, A. Katz-Hillel, M. Feldman, G. Berke, and L Eisenbach. 1995 Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides Nature Med. 1:1179.
15. Mayordomo, J I., T. Zorina, W. J. Storkus, L. Zitvogel, C. Celluci, L D Fallo, C. J. M Melief, S. T. Ildstad, W. M Kast, A. B. Deleo, and M. T Lotze. 1995 Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med 1:1297.
16. Kast, W. M., R Offringa, P J. Peters, A. Voordouw, R H. Meloen, A. J. van der Eb, and C. J. M. Melief. 1989. Eradication of Adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes Cell 59:603
17. Toes, R. E. M., R. Offringa, R. J. J. Blom, R M. P Brandt, A. J. van der Eb, C. J. M. Melief, and W M Kast. 1995. An adenovirus type 5 early region 1B-encoded CTL epitope mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene. J. Immunol 154.3396.
18. Gousepahl, H , M Kraft, Ch Boulin, and R. W. Frank. 1990 Automated multiple peptide sythesis with BOP activation. In Proceedings of the 11th American Peptide Symposium. J E Rivier and G R. Manshall, eds ESCOM, Leiden, p. 1003.
19. Kast, W M., and C. J. M. Melief 1991 Fine peptide specificity of cytotoxic T lymphocytes directed against adenovirus-induced tumours and peptide-MHC binding. Int. J. Cancer 6 90
20. Sharrock, C. E. M , E Kaminski, and S. Man. 1990 Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 11 281.
21. Strybosch, L. W. G., W. A. Buurman, R. J. M. Does, P. H. Zinken, and G. Groenewegen. 1987. Limiting dilution assays: experimental design and statistical analysis. J. Immunol. Methods 97:133.
22. Yang, Y., H C. J. Ertl, and I. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433.
23. Yang, Y., Q Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004.
24. Dai, Y., E. M. Schwarz, D. Gu, W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401.
25. Ensinger, M. J., and H. S. Ginsberg. 1972. Selection and preliminary characterization of temperature sensitive mutants of type 5 adenovirns. J. Virol. 10:328.
26. Mamalaki, C., Y. Tanaka, P Corbella, P. Chandler, E. Simpson, and D. Kioussis. 1993 T cell deletion follows chronic antigen specific T cell activation in vivo. Int Immunol. 5.1285.
27. Aichele, P., D. Kyburz, P. S. Ohashi, B. Odermatt, R. M. Zinkernagel, H Hengartner, and H. Pircher. 1994. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad Sci. USA 91.444.
28. Aichele, P., K. Brduscha-Riem, R. M. Zinkernagel, H. Hengartner, and H. Pircher. 1995. T cell priming versus T cell tolerance induced by synthetic peptides J. Exp. Med. 182:261.
29. Huang, L , G. Soldevilla, M. Leeker, R Flavell, and I. N. Crispe. 1994. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1:741.
30. Singer, G. G , and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not in thymic deletion of T lymphocytes in T cell receptor transgenic mice Immunity 1 366.
31. + T cells to an antigen that no longer serves as a target. J. Exp. Med. 178:933.
32. Huang, A. Y. C., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D Pardoll, and H. Levitsky. 1994. Role of bone-marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
33. Rawle, F. C , B. B. Knowles, R. P Ricciardi, V. Brachmachen, P. Duerksen-Hughes, W. S. M. Wold, and L. R. Gooding. 1991. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. J. Immunol. 146:3977.
34. Zinkernagel, R. M., D. Moskophidis, T. Kündig, S. Oehen, H. Pircher, and H. Hengartner. 1993. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol. Rev. 131:199
35. Crispe, I. N. 1994. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1:347.
36. Smilek, D. E., D C. Wraith, S. Hodgkinson, S. Dwidedy, L. Steinanm, and H. O. McDevitt. 1991. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 88:9633.